Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVD in Refractory Stage 4 Neuroblastoma
NCT00392340Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan, vincristine, doxorubicin in neuroblastoma, sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
topotecanvincristinedoxorubicin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00392340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392340.